MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) by 2.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 138,781 shares of the company’s stock after buying an additional 3,305 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in LifeStance Health Group were worth $1,023,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after acquiring an additional 784,818 shares during the period. Jennison Associates LLC boosted its stake in LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock worth $59,597,000 after purchasing an additional 5,949,438 shares during the period. Wellington Management Group LLP grew its holdings in LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock valued at $38,886,000 after buying an additional 445,796 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in LifeStance Health Group by 87.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock valued at $25,977,000 after buying an additional 1,643,390 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of LifeStance Health Group by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock valued at $25,546,000 after buying an additional 13,293 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on LFST shares. KeyCorp started coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an “overweight” rating and a $9.00 target price for the company. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. Finally, William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $8.30.

Check Out Our Latest Stock Report on LifeStance Health Group

Insider Transactions at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company’s stock, valued at $2,344,689. This trade represents a 5.25% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 3.20% of the company’s stock.

LifeStance Health Group Price Performance

LFST stock opened at $5.49 on Monday. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $8.61. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a fifty day simple moving average of $6.41 and a two-hundred day simple moving average of $7.17. The firm has a market capitalization of $2.13 billion, a P/E ratio of -21.12 and a beta of 1.30.

LifeStance Health Group Company Profile

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Recommended Stories

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report).

Institutional Ownership by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.